title: Probing interactions of Vpu from HIV-1 with amiloride-based compounds.
abstract: Viral ion channels or viroporins are short membrane proteins that participate in wide-ranging functions including virus replication and entry, assembly, and virus release. One such viroporin is the 81 amino acid residue Vpu protein derived from HIV-1. This protein consists of one transmembrane (TM) and two cytoplasmic helical domains, the former of which oligomerises to form cation-selective ion channels. In this study, we investigate the binding properties of amiloride compounds to Vpu embedded into liposomes using surface plasmon resonance (SPR). We explore the Vpu ion channel inhibitor, hexamethylene amiloride (HMA), as a molecular tool to examine the potential interactive role of key TM residues, Trp23, Ser24, and Glu29, in terms of positioning of these residues on the channel pore and the orientation of its constituent helices. The study provides experimental support that a direct interaction between Ser24 and HMA occurs and that this residue is most likely located in the channel pore. Mutation of Trp23 does not impact HMA affinity suggesting no direct involvement in binding and that this residue is lipid facing. These findings indicate that small molecules such as amilorides are capable of specifically interacting with Vpu ion channels. Although a correlation between ion channel and functional activity cannot be dismissed, alternative mechanisms involving protein-protein interactions may play an important role in the efficacy of these compounds.
authors.affiliation: John Curtin School of Medical Research, Australian National University, PO Box 334, Canberra, ACT 2601, Australia.
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Rosenberg
authors.affiliation: John Curtin School of Medical Research, Australian National University, PO Box 334, Canberra, ACT 2601, Australia.
authors.forename: Llara M
authors.initials: LM
authors.lastname: Weaver
authors.affiliation: John Curtin School of Medical Research, Australian National University, PO Box 334, Canberra, ACT 2601, Australia. Electronic address: Marco.Casarotto@anu.edu.au.
authors.forename: Marco G
authors.initials: MG
authors.lastname: Casarotto
mesh_terms: D000584:Amiloride / Q000494:pharmacology; D000595:Amino Acid Sequence / Q000187:drug effects; D015497:HIV-1 / Q000737:chemistry* / Q000472:pathogenicity; D054298:Human Immunodeficiency Virus Proteins / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D007473:Ion Channels / Q000737:chemistry / Q000378:metabolism; D008081:Liposomes / Q000737:chemistry*; D009154:Mutation; D020349:Surface Plasmon Resonance; D054334:Viral Regulatory and Accessory Proteins / Q000737:chemistry* / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects; D000086082:Viroporin Proteins
chemical_list: D000584:Amiloride; D054298:Human Immunodeficiency Virus Proteins; D007473:Ion Channels; D008081:Liposomes; D054334:Viral Regulatory and Accessory Proteins; C514859:vpu protein, Human immunodeficiency virus 1; D000086082:Viroporin Proteins
keywords: Amiloride; Drug binding; HIV-AIDS; Viral ion channel; Vpu